ArticleCureus2025
Role of Gestosis Scoring and Pentamarker in Prediction of Pregnancy-Induced Hypertension (PIH) in Primigravida.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPregnancy-induced hypertension (PIH) remains a major cause of maternal and fetal complications, highlighting the need for early prediction and intervention. The gestosis score and pentamarker analysis are emerging tools for identifying high-risk pregnancies. This study aims to evaluate the effectiveness of these markers in predicting PIH in primigravida patients to enhance maternal and fetal outcomes.
objectiveThe primary objective of this study is to assess the role of the gestosis score and pentamarker in predicting early PIH in primigravida women. By analyzing their predictive accuracy, the study aims to establish these tools as reliable screening methods for timely intervention and management. MATERIALS AND
methodsA prospective study was conducted in the Department of Obstetrics and Gynecology at IMS, BHU, in collaboration with the Department of Radiology. A total of 120 first-trimester primigravida women were enrolled. Participants underwent detailed history-taking, clinical examination, and laboratory investigations, including calculation of the gestosis score and Pentamarker analysis. Uterine artery Doppler studies were performed in both the first and second trimesters to assess flow changes. Statistical analysis was conducted to evaluate correlations between these markers and PIH development.
resultsThe study found that out of 120 primigravida patients, 29.17% had high gestosis scores, significantly linked to increased risk of preeclampsia and adverse neonatal outcomes. Positive pentamarker reports were also associated with higher preeclampsia incidence and NICU admissions. Combined gestosis score and pentamarker assessment improved predictive accuracy, supporting their role in early PIH detection and management.
conclusionEarly screening using the gestosis score and pentamarker analysis can help identify primigravida women at risk for PIH, enabling timely intervention. Further studies are needed to validate the effectiveness of these tools in larger populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.